DJ Orthopedics Expands in Rehabilitation
Executive Summary
Often overlooked in all the interest in orthopedics is the non-surgical side, a product area that includes a wide range of supports and braces--soft goods as opposed to hard implants--used to treat a number of musculoskeletal problems. Indeed, given that non-surgical approaches represent an important front line in treatment options for patients with such problems-in spine, for example, surgical interventions are used in barely more than 10% of all patients complaining of back pain-it's surprising that more attention isn't paid to this segment. One company that has made the non-surgical orthopedics market a focus is dj Orthopedics Inc. who, with its acquisition of Aircast Inc. further enhances what is already a number-one market share position in the $1.2 billion US rehabilitation products market.
You may also be interested in...
Next-Gen ADCs: Araris CEO Highlights Potential In Linker Technology
In Vivo sat down with 2023 Rising Leader Philipp Spycher, CEO of Araris Biotech, to discuss trends in antibody-drug conjugate R&D, and how Araris hopes to disrupt today’s chemotherapy treatment paradigm with novel linker technology.
FDA Panel Will Have To Weigh Pediatric Cancer Drug’s ‘Higher Level’ Of Uncertainty Against Rare, Devastating Disease
US WorldMeds NDA package for eflornithine for high-risk neuroblastoma provides “a higher level of uncertainty than is typically seen in oncology applications,” agency says. Though FDA seems largely satisfied with the sponsor’s externally controlled study, confirmatory evidence may be lacking.
Novo Files Suit Over IRA As It Joins Others In Signing On To Price Negotiations
The nine drug manufacturers with products selected for Medicare drug price negotiations have agreed to participate in the program. Seven of them now have pending suits challenging the Inflation Reduction Act program with Novo’s recent complaint, which objects to the aggregation of its insulin products.